Panda & Friends Volunteer Monthly Feature Poster | Issue 1
Powered by love, our Panda Group volunteers have built the warmth and order we cherish today. The community's stability relies entirely on their dedication.
They are far more than just functional Q&A helpers. The original intention behind Momocha's "Volunteer Monthly Feature Poster" is to let every volunteer be seen in a more three-dimensional, authentic, and warm way.
Every volunteer is a cherished light in this community. ✨✨✨
Through these posters, we hope to introduce you to the real people behind the screens—their hobbies, life stories, personality tags, and even those small yet touching moments of daily life.
🎉🎉🎉 Today, we proudly launch Issue 1, honoring the behind-the-scenes volunteers who quietly recruit new members. They may rarely step into the spotlight, but they remain the most reliable gatekeepers of our community. ❤️❤️❤️
Small Donation Channel
Certified by Charity China
Patient Stories | Click text to jump directly
A Middle-Aged Beijinger's Journal Against Advanced Colon Cancer | Panda Star's Anti-Cancer Magic | A-Ming: Accompanying My Mom Through Two Years of Treatment for Colon Cancer with Liver & Lung Metastases | Qingcao: Sharing the Treatment Journey for Colon Cancer with Liver Metastasis | Deep Sibling Bond: 4 Years of Treatment for Colon Cancer with Liver Metastasis | Xiao Li: A Patient's Personal Cancer Journey | Sister Xiuxiu: Treatment Path for Colon Cancer with Liver & Ovarian Metastases | Brother Guo: Tenacious Treatment Journey for Colon Cancer with Peritoneal Metastasis | Naonao: Self-Rescue Journey After Recurrence of Colon Cancer at 27 | Sister Tudou: 7-Year Cancer Battle with Lung & Brain Metastases | Yuanyuan: The Cancer-Fighting Beauty, Living with a Smile | Jinxia: 4-Year Treatment Journey for HER2-Positive Gastric Cancer | The Grumpy Grandpa's Gastric Cancer Battle | Mickey: Treatment Journey for Advanced Gastric Cancer at 31 | Alison: Treatment for HER2-Positive Advanced Colon Cancer | From Stage IV Gastric Cancer to Complete Remission | 78 Liver Metastases Are Not a Death Sentence | The Advanced Cancer Patient in the ICU for Infection Is Now Tumor-Free | Panda Group Story: Weihua 1 | From Diagnosis to Recurrence | Panda Group Story: Yang Yong | Striving Unceasingly | The Harsh Truth Behind Treatment Value: Why Some Patients Are Advised Against Seeking Care in Beijing, Shanghai, or Guangzhou | Cancer Blogger Fengzi Passes Away: Who Will Care for Young Patients Fighting Alone? | Panda & Friends | Lao Chen: Experience in CAR-T Clinical Trials, Over 3 Years with Colon Cancer Metastases | Sister Yangguang: Life Should Not Lose Its Color Due to Illness | Patient Story | Nine Years of Fighting Advanced Cancer: Happiness Still Found Me | Patient Story | At 33, After Being Given a Cancer "Death Sentence" | Patient Story | Post-85s Solo Cancer Journey, To Be Continued (Part 1) | Nine Years of Fighting Advanced Cancer: Happiness Still Found Me | At 33, After Being Given a Cancer "Death Sentence"
Doctor-Patient Communication | Click text to jump directly
Prof. Shen Lin, Peking University Cancer Hospital: 2023 Advances in Colon Cancer Immunotherapy | Step-by-Step Guide for Colon & Gastric Cancer Patients on Seeking Care
Prof. Xing Baocai, Peking University Cancer Hospital: Doctor-Patient Communication on Colon Cancer Liver Metastasis
Prof. Chen Gong, Sun Yat-sen University Cancer Center: Can Surgery Be Done Immediately After Colorectal Cancer Diagnosis? | On Surgery for Colorectal Peritoneal Metastasis | On Treatment Strategies for Colorectal Liver & Lung Metastasis | Maintenance Therapy & Neoadjuvant Chemotherapy for Colon Cancer | Patient Group Case Analysis Q&A (1) | Patient Group Case Analysis Q&A (2)
Prof. Cai Guoxiang, Fudan University Shanghai Cancer Center: Transcript of Patient Group Q&A
Prof. Wang Fenghua, Sun Yat-sen University Cancer Center: Transcript of Patient Group Communication
Dr. Xiao Jian, The Sixth Affiliated Hospital of Sun Yat-sen University: Chemotherapy, Targeted Therapy & Immunotherapy for Advanced Gastric Cancer
▽ Click "Read Original" to join the discussion